GLP-1 Therapy in New York NY Could Be the Long-Term Weight Loss Solution You’ve Been Looking For
Gaining weight is frustratingly easy for most people. Losing weight is not nearly as easy. Unfortunately, the $33 billion weight loss industry has offered consumers a lot by way of hype, but not much when it comes to effective solutions. A new solution might be changing it all. GLP-1 Therapy in New York NY may finally provide long-term weight loss answers, according to studies.
What is GLP-1 Therapy in New York NY?
Semaglutide, also known as GLP-1 or glucagon-like peptide-1, affects the areas of the brain that regulate your digestion, hunger, and feeling full. It also slows how quickly your stomach empties.
Originally, GLP-1 Therapy in New York NY was approved strictly for the treatment of type 2 diabetes. It didn’t take long for researchers to identify a beneficial side effect, though: weight loss. Drug trials showed that those taking semaglutide lost more than 12% of their body weight, on average. One in three people actually lost more than 20% of their body weight.
Are There Side Effects of GLP-1 Therapy in New York NY?
There can be side effects, the most common of which are constipation, diarrhea, nausea, and fatigue. But, by merely changing the dosage, these side effects were largely eliminated. Remember that the only other medical option with comparable results is bariatric surgery. With that type of major surgery, the risks can be considerable – especially compared to the relatively mild side effects of semaglutide.
The Numbers Speak for Themselves When it Comes to GLP-1 Therapy in New York NY
If you think that everything you’re read up until now sounds too good to be true, you are not alone. It makes one wonder: Does semaglutide live up to its publicity? These are actual findings from medication trials. Over the course of 52 weeks, a study designed to find the semaglutide dosages that work best discovered weight reduction of up to 16.2% relative to baseline. 12.4% of body weight was lost, or an average of 37 pounds.
In a trial that incorporated dietary and lifestyle modifications, the placebo group lost 2.4% of their body weight, compared to the semaglutide group, who lost 15-20%.
Being Overweight Comes with Many Complications
Being overweight has serious health implications. Specifically, it is linked to type 2 diabetes, high blood pressure, high cholesterol (especially LDL or “bad” cholesterol), heart disease and stroke, fatty liver and gallbladder disease, cancer (especially breast and colon cancer), sleep apnea, arthritis (especially in weight-bearing joints), and lower back pain.
Are You Having a Hard Time Shedding Pounds?
Do you want to know if GLP-1 Therapy in New York NY can be the best choice for you? Getting more information is simple. Call us at 800-859-7511 for a free consultation or fill out our online contact form.